Home › Markets › Health Care › BLLN

BillionToOne Inc. (BLLN)

BLLN trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$94.44
+1.47% on the day
Market cap
$4.5B
Mid cap
Revenue · 2025
$305.1M
+100.0% on 2024
Net income · 2025
$7.5M
2.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerBLLN on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2025
SEC CIK0002070849
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$305.1M
Net income$7.5M
Operating income$16.0M
Net margin2.4%
Operating margin5.3%
Revenue growth+100.0%
Cash$496.0M
Total assets$632.7M
P/E (computed)597.8×
P/S (computed)14.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-11-06
Latest annual report10-K2026-03-11
Latest quarterly / interim10-Q2026-08-05
Latest current report8-K2026-08-05
Latest proxyDEFA14A2026-04-21

Source: SEC EDGAR submissions feed, 160 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.7%
1 month-6.6%
3 months-24.1%
Year to date+19.0%
1 yearNot enough price history
From 52-week high-35.1%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
CONConcentra Group Holdings Parent Inc.$37.540.00%$4.8B
RDNTRadNet Inc.$71.51+0.03%$5.6B
VCYTVeracyte Inc.$43.11-2.07%$3.5B
CDNACareDx Inc.$65.43+3.66%$3.4B
GRALGRAIL Inc. Common Stock$140.35+2.17%$6.3B
CELCCelcuity Inc.$63.19-4.04%$3.1B
ACHCAcadia Healthcare Company Inc.$30.23+0.50%$2.8B
CLOVClover Health Investments Corp.$4.81+0.63%$2.6B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier